Axsome Therapeutics AXSM Goodwill
Goodwill at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Axsome Therapeutics's goodwill.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Axsome Therapeutics's goodwill?
- Axsome Therapeutics (AXSM) reported goodwill of $12.04M in Q1 2026.
- How has Axsome Therapeutics's goodwill changed year-over-year?
- Axsome Therapeutics's goodwill decreased by 0.0% year-over-year, from $12.04M to $12.04M.
- What is the long-term trend for Axsome Therapeutics's goodwill?
- Over 3 years (2022 to 2025), Axsome Therapeutics's goodwill has grown at a 5.3% compound annual growth rate (CAGR), from $10.31M to $12.04M.
- What does goodwill mean?
- The premium paid over the fair value of assets when acquiring another company.
- How do you interpret goodwill?
- High levels suggest past acquisition activity; impairment charges indicate that the value of acquired assets has declined.
- How does goodwill compare across companies?
- Common in companies that grow through M&A; less common in purely organic, early-stage research firms.